rheumatoid arthritis Archives
Rheumatoid arthritis and heart disease: a common path
Aug. 25, 2022—An increase in certain antibodies in patients with rheumatoid arthritis can serve as a predictive biomarker for cardiovascular disease, Vanderbilt researchers have discovered.
Rheumatoid arthritis: special deliveries
Mar. 28, 2022—Birth outcomes including postpartum infection and blood transfusion were similar in women with and without rheumatoid arthritis, and continued use of disease-modifying antirheumatic drugs and biologics is recommended to limit steroid exposure.
Rheumatoid arthritis drug combined with standard of care may help reduce mortality for hospitalized COVID-19 patients
Sep. 2, 2021—Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.
Microbial RNA and rheumatoid arthritis
Jan. 11, 2021—Small RNAs — short stretches of genetic material — from microbes may be playing a role in rheumatoid arthritis and other autoimmune diseases.
Rheumatoid arthritis patients on Medicare seeing increased out-of-pocket costs for specialty medications
May. 7, 2020—After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study finds.
Bioactive lipids and rheumatoid arthritis
Nov. 1, 2017—An enzyme that produces bioactive fatty acids has elevated activity in patients with rheumatoid arthritis, supporting further studies to understand its biologic roles in the disease.
Rheumatoid subtypes explored by PheWAS
Oct. 7, 2016—A computer-based method pioneered at Vanderbilt is being used to compare subtypes of rheumatoid arthritis.
Grant bolsters rheumatoid arthritis research
Feb. 25, 2016—C. Michael Stein, MBChB., and his colleagues at Vanderbilt University Medical Center have received a five-year, $1.35 million award from the Arthritis Foundation to develop new biomarkers for rheumatoid arthritis that also may revolutionize treatment.
Study links opioids, infection risk for patients with rheumatoid arthritis
Nov. 19, 2015—Use of opioid analgesics is associated with an increased risk of hospitalization for serious infections among patients with rheumatoid arthritis, according to a Vanderbilt study published in Arthritis & Rheumatology.
Major grant spurs deeper look into ‘good cholesterol’
Aug. 21, 2014—In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis.